Bessemer Group’s CalciMedica CALC Stock Holding History

Bessemer Group’s Portfolio CALC Stock Details CALC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-385	Closed	-$146K	–	1667
2021 Q2	$146K	Hold	385	–	–	﹤0.01%	867
2021 Q1	$150K	Buy	+385	New	+$576K	﹤0.01%	801

Other funds holding CALC

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

First Manhattan New York $39.2B AUM 21.04% 1-Year Est. Return

Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bessemer Group's CALC Position: Q3 2021 in Review

Bessemer Group sold out of CalciMedica (CALC) in Q3 2021, closing a stake of 385 shares — an estimated $146K sold.

Bessemer Group first reported a position in CALC in Q1 2021 and held it in 2 quarters. The position peaked at $150K in Q1 2021. 26 funds tracked by Wall St. Rank hold CALC as of Q3 2021.

Bessemer Group reported no remaining CalciMedica position as of Q3 2021 after selling out during the quarter.
Bessemer Group sold 385 CalciMedica shares in Q3 2021, an estimated $146K.
Bessemer Group first reported a position in CalciMedica in Q1 2021 and held it in 2 quarters.
Bessemer Group's CalciMedica position peaked at $150K in Q1 2021.
26 funds tracked by Wall St. Rank held CalciMedica as of Q3 2021.

Based on Bessemer Group's 13F filing for Q3 2021, filed 12 Nov 2021.